Business Details
Innovative Biopharma & Medical Device Solutions
Vivera Pharmaceuticals is a science-driven biopharma and medtech company headquartered in Southern California. Our mission centers on addressing critical healthcare challenges through innovative therapies and advanced medical technologies. We hold global exclusivity to the patented TABMELT sublingual drug delivery system and own issued patents for ZICOH, an intelligent dose-controlled electronic prescription dispensing device, and MDZone, a portable telemedicine station. With vertically integrated operations spanning patented technologies, manufacturing, and distribution, we deliver solutions across biosciences, medical devices, and advanced diagnostics.Our commitment to non-addictive pain management and patient-centric care drives our research and development efforts. Through Vivera Cares, our nonprofit initiative, we extend resources to underserved communities, including Tribal Nations and frontline workers, to improve global health equity. Our leadership team brings deep regulatory and industry expertise, exemplified by strategic hires like former FDA investigator Dennis Moore, ensuring compliance and innovation in every project we pursue.
Services
TABMELT sublingual drug delivery
ZICOH intelligent dispensing device
MDZone telemedicine station
Advanced diagnostics
Biosciences research
Medical device development
Non-addictive pain therapies
Speech fluency evaluation
Opioid crisis solutions
Telemedicine technologies
Highlights and features
- We hold global exclusivity to the patented TABMELT sublingual drug delivery system.
- Our ZICOH device provides intelligent, dose-controlled electronic prescription dispensing.
- We maintain a vertically integrated structure for quality control across development to distribution.
- Our team includes former FDA investigator Dennis Moore for regulatory expertise.
- We advance non-addictive pain management solutions through rigorous clinical research.
Services
TABMELT sublingual drug delivery
Our TABMELT technology offers a patented sublingual drug delivery method that enhances medication absorption and patient compliance. This innovative platform enables rapid onset of action for pharmaceuticals while maintaining precise dosage control. The system's versatility supports development of non-addictive pain management solutions and psychiatric therapies.
ZICOH intelligent dispensing device
ZICOH is an FDA-regulated electronic prescription dispensing device featuring dose-controlled administration and digital tracking capabilities. This intelligent system improves medication adherence while providing real-time usage data for healthcare providers. The patented technology ensures secure, accurate medication management for chronic conditions.
MDZone telemedicine station
MDZone is a portable telemedicine station enabling remote patient monitoring and virtual consultations. This medical device integrates diagnostic tools with secure communication channels for improved healthcare accessibility. The platform supports chronic disease management and post-operative care in underserved communities.
Advanced diagnostics
Our advanced diagnostics division develops cutting-edge testing methodologies for early disease detection and personalized treatment planning. The portfolio includes molecular diagnostics and point-of-care testing solutions that enhance clinical decision-making. These innovations improve patient outcomes through faster, more accurate diagnoses.
Biosciences research
Biosciences initiatives focus on developing novel therapeutics for neurological and psychiatric disorders. The research pipeline includes CRADA collaborations with NIH institutes for stuttering disorder treatments. Our neuroscience division leverages TABMELT technology to create targeted therapies for mental health conditions.
People
Dennis Moore
Regulatory and Compliance Advisor
Former FDA investigator with 20+ years of regulatory expertise guiding pharmaceutical compliance and approval pathways. Specializes in medical device regulations and quality system audits to ensure adherence to global standards.
Questions
What medical technologies does Vivera develop?
We develop patented solutions including TABMELT sublingual drug delivery, ZICOH intelligent dispensing devices, and MDZone telemedicine stations for improved patient care.
How does Vivera address the opioid crisis?
Our non-addictive pain management therapies leverage TABMELT technology to provide effective alternatives to traditional opioids while maintaining strict dosage control.
What research partnerships exist?
We collaborate with NIH institutes through CRADAs to develop treatments for neurological disorders like stuttering, combining our technology with government research expertise.
How does Vivera support underserved communities?
Through Vivera Cares, we provide medical resources and technologies to Tribal Nations and frontline workers, addressing healthcare disparities during crises like the opioid epidemic.
What are Vivera's core business divisions?
We operate four main divisions: medical devices, advanced diagnostics, biosciences, and medical technologies, all integrated under our pharmaceutical innovation umbrella.
Videos
